Delivering low-dose CT screening for lung cancer: a pragmatic approach

Carolyn Horst,Anand Devaraj,Sophie Tisi,Sam M Janes,Jennifer L Dickson,Arjun Nair,Mamta Ruparel

doi:10.1136/thoraxjnl-2020-215131

Abstract

Lung cancer kills an estimated 35 000 people in the UK every year. Despite the improvements in treating late-stage disease, lung cancer outcomes have changed little in the last 40...

Highlights

Lung cancer kills an estimated 35,000 people in the UK every year
Deviations were made from British Thoracic Society (BTS) guidelines either to minimise the burden on secondary care colleagues or where new evidence suggests a safe but more conservative approach
Pragmatic approach was taken to thyroid nodules and other nonmalignant findings. While these protocols may appear complicated, because bespoke reporting proformas and software have been developed for use in SUMMIT, and findings indicated therein are ingested into the software directly, users are automatically presented with the ‘correct’ management for each scan, and are not required to https://mc.manuscriptcentral.com/thorax reference these protocols directly themselves

Summary

Introduction

Lung cancer kills an estimated 35,000 people in the UK every year. Despite the improvements in treating late stage disease, lung cancer outcomes have changed little in the last 40 years. Deviations were made from BTS guidelines either to minimise the burden on secondary care colleagues (e.g. where MDT referral is not made until a growing nodule is ≥200mm3) or where new evidence suggests a safe but more conservative approach (for example, with GGNs, which often resolve or, if persistent, are unlikely to require immediate intervention).

Objectives

Results

Conclusion